Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

Clinical trial NCT04446182 · TERMINATED

Trial details

NCT number: NCT04446182
Sponsor: University of Utah
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft-versus-host-disease

Start date: 2021-01-29
Primary completion: 2022-03-29
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.